Create a free starter account, or log in.

Get access to four free articles per month, as well as our Decisive Edge Newsletters and Daily News Bulletin.

Email Address

Password

Forgot your password? Reset by clicking here

Create a Password

[[ req.met ? '✓' : '•' ]] [[ req.text ]]

Re-enter Password

Passwords do not match

First Name

Last Name

Country

Confirm your account

Please enter the four-digit pin below that has been emailed to you.

Didn't receive the pin yet?

This pin expires in 20 minutes.

[[ error ]]

By creating an account, you agree to the Terms of Service and Privacy Policy.

Stay informed with Shephard's award-winning journalism. Unlock unlimited access and in-depth analysis with a corporate or individual subscription.

Explore your options here

I/ITSEC 2017: US Army to acquire WIAMan

30th November 2017 - 12:00 GMT | by Beth Maundrill in Orlando

RSS

The US Army is set to invest in the new Warrior Injury Assessment Manikin (WIAMan) anthropomorphic test device (ATD) which is set to go into to production in 2018.

The main objective of the WIAMAN is to create a scientifically valid under-body blast (UBB) injury assessment capability when testing ground vehicles. The US Army's Research Laboratory (ARL) showcased the manikin at I/ITSEC 2017.

The project began in 2010 as part of the Army Research Laboratory, which was run out of the ARL. Now that the capability is moving towards acquisition it is being moved into PEO STRI for that process

Already have an account? Log in